Company Profile
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2022, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
At the end of 2022, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Key Executives
Chief Executive Officer | Carlo Rosa |
Chief Financial Officer | Piergiorgio Pedron |
Investor Relations Director | Riccardo Fava |
Chief Communication Officer | Riccardo Fava |
Chief Human Resources Officer | Stefano Ronchi |
Key Figures
Millenium | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Net sales | 1,361,138 | 1,237,654 | 881,305 | 706,319 | 669,200 |
Income from ordinary activities | 1,361,138 | 1,237,654 | 881,305 | 706,319 | 669,200 |
Operating income | 351,260 | 419,499 | 324,226 | 217,861 | 204,500 |
Cost of financial indebtedness net | 34,611 | 22,506 | 1,375 | 1,279 | 0 |
Equity-accounted companies contribution to income | |||||
Net profit from discontinued activities | |||||
Net income | 240,110 | 310,732 | 248,296 | 175,735 | 158,100 |
Net income (Group share) | 240,907 | 310,968 | 247,871 | 175,735 | 158,100 |
Fiscal year end | 12.22 | 12.21 | 12.2 | 12.19 | 12.18 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
Account Standards |
Shareholder information
Finde SS | 44.98 % |
Free float | 39.43 % |
Carlo Rosa | 8.36 % |
Chen Menachem Even | 4.2 % |
T. Rowe Price Associates, Inc. | 3.03 % |
Address
DiaSorin S.p.A.
Via
IT-13040 Saluggia, Piemonte
Italy
Phone number: +39 (0)161 487 1
https://diasoringroup.com/
Please contact MyQuestion.Italy@euronext.com for Company Profile support.